Tetanus boosters, MMR for measles, mumps and rubella ... Varies by Year Major manufacturers of the vaccine only have 6-8 months lead times. The current stock
GlaxoSmithKline, which also makes MMR, yesterday denied that its decision to stop making Ervevax, its single rubella vaccine, had been influenced by the Government, which backs the Measles, Mumps and Rubella jab ... has enough in …
and $2.1 billion for MMR (about $50 per share in cash and stock), making it a $9 billion acquisition in total. McMoRan …
Late last year, Mossberg made news when it introduced the Mossberg Modern Rifle (MMR), an affordable AR-style rifle chambered ... lacks some of the portability of a collapsible, six-position stock, but it delivers a better cheek weld when …
As part of its planning for future growth, MMR has had the analysts in for some fireside chats. As a result there has been a flurry of broker reports on the stock. Interesting reading, too, as they have all set share price targets for MMR that are …
$5.5 billion in cash consideration and 91 million shares of FCX stock (valued at $2.8 billion as of May 31, 2013) and …
Roche Holdings AG RHHBY recently announced FDA clearance for the VENTANA MMR IHC Panel for immunohistochemistry (IHC ... The FDA approval further broadens Roche’s diagnostic portfolio. Roche’s stock has …
... the MMR Tactical or the MMR Hunter, you’re in the business. First up: the Tactical. It’s an M4-profiled carbine, with a 16.25″ barrel threaded and fit with an A2 flash hider and your choice of a standard fixed stock or (also quite standard ...